Imuno Therapeutics Alternatives & Competitors
12 companies similar to Imuno Therapeutics — Identifying true targets in oncology and autoimmune disorders
Companies similar to Imuno Therapeutics
Rgenta Therapeutics Inc.
We unlock the therapeutic potentials of highly disease-relevant targets undruggable by sma...
Woburn, United States
Nimbus Therapeutics
We develop breakthrough medicines for patients through precision small molecule design.
Boston, United States
-logo.jpg "Ikena Oncology (Merged with ImageneBio)"){kind=logo}
Ikena Oncology (Merged with ImageneBio)
Ikena merged with ImageneBio on in July 2025. Please visit https://inmagenebio.com/ for mo...
Boston, United States
Gritstone bio
A lean biotech company aiming to develop revolutionary immune-based treatment for various...
Emeryville, United States
Rival Readout
Competing with Imuno Therapeutics? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Breakpoint Therapeutics
Modulating DNA damage responses to cure cancer
Hamburg, Germany
AtG Therapeutics
Overcoming Tumor Adaptation - inhibiting escape mechanisms both in treatment naive and res...
Spain
Hummingbird Bioscience
Hummingbird Bioscience is a biotherapeutics company working at the interface of AI and hum...
Singapore, Singapore
Viewpoint Molecular Targeting, Inc.
Targeted α-Particle Radiotherapy for Cancer
Coralville, United States
Sumitomo Pharma Oncology
is part of Sumitomo Pharma America as of July 2023
Cambridge, United States
Enlaza Therapeutics
Pioneering Covalent Biologics
San Diego, United States
Asylia Therapeutics
Innovative therapies reshaping immune responses against autoimmune, cancer, and infectious...
STORM Therapeutics Limited
Harnessing the power of RNA modification
Cambridge, United Kingdom
About Imuno Therapeutics
Imuno Therapeutics, founded in 2020 and headquartered in The Netherlands, is at the forefront of leveraging machine learning for drug discovery in the fields of oncology and autoimmune disorders. Their slogan, "Identifying true targets in oncology and autoimmune disorders," encapsulates their innovative approach. The c...
Development of next-generation immunotherapies, Engineering precision-targeted intracellular antigen therapies, Partnering for immunotherapy advancements
Patients with hard-to-treat diseases, Oncology and autoimmune disease communities, Biotechnology and pharmaceutical partners
Structure-based Discovery, Cancer-specific Epitopes, Therapeutic Targeting, Novel Therapeutic Strategies, Oncology, Autoimmune Disorders, Cross-reactive Epitopes, In-vitro Safety Studies, Personalized Medicine, Tumor-specific Therapy, Drug Discovery, Bioinformatics, Epitope Identification, Safe Therapies Development
B2B, D2C, Platform
Licensing, Performance Based, Service Fee
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Imuno Therapeutics: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Imuno Therapeutics on 21 May 2026. The 12 companies listed here were last checked between 12 Sep 2024 and 22 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
